Guideline

Guideline: preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups

Year of Publication

2017

Issuing Institution

World Health Organization

Links

WHO IRIS,WHO IRIS

Recommendations

3 included recommendations

Preventive chemotherapy (deworming), using annual or biannuala single-dose albendazole (400 mg) or mebendazole (500 mg), is recommended as a public health intervention for all young children (12-23 months of age), preschool (24-59 months of age) and school-age children living in areas where the baseline prevalence of any soil-transmitted infection is 20% or higher among children, in order to reduce the worm burden of soil-transmitted helminth infections

Status

Updated

Recommended in favor

Strong

Certainty of evidence

Low

Preventive chemotherapy (deworming), using annual or biannual single-dose albendazole (400 mg) or mebendazole (500 mg), is recommended as a public health intervention for all non-pregnant adolescent girls (10–19 years of age) and non-pregnant women of reproductive age (15–49 years of age) living in areas where the baseline prevalence of any soil-transmitted helminth infection is 20% or higher among non-pregnant adolescent girls and non-pregnant women of reproductive age, in order to reduce the worm burden of soil-transmitted helminth infection

Status

Maintained

Recommended in favor

Strong

Certainty of evidence

Moderate

Preventive chemotherapy (deworming), using single-dose albendazole (400 mg) or mebendazole (500 mg), is recommended as a public health intervention for pregnant women, after the first trimester, living in areas where both: (i) the baseline prevalence of hookworm and/or T. trichiura infection is 20% or higher among pregnant women, and (ii) anaemia is a severe public health problem, with a prevalence of 40% or higher among pregnant women,a in order to reduce the worm burden of hookworm and T. trichiura infection

Status

Maintained

Recommended in favor

Conditional

Certainty of evidence

Moderate